RNA — AVIDITY BIOSCIENCES INC

Ownership history in Boxer Capital, LLC  ·  19 quarters on record

This page tracks every 13F SEC filing in which Boxer Capital, LLC reported a position in AVIDITY BIOSCIENCES INC (RNA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
3.89% (2024 Q3)
Avg. % of fund
1.45%
First filed
2020 Q2
Last filed
2024 Q4
Quarters held
19
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2024 Q4 UNCHANGED 1,727,388 — 0% 3.89% $79.3M —
2024 Q3 UNCHANGED 1,727,388 — 0% 3.89% $79.3M —
2024 Q2 UNCHANGED 1,727,388 — 0% 3.72% $70.6M —
2024 Q1 ADDED 1,727,388 +606,061 +54.0% 2.18% $44.1M —
15 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    RNA price (monthly, adj. close)

Other funds also holding RNA

As of 2025 Q4 — sorted by position size

ALETHEA CAPITAL MANAGEMENT, LLC 3Y 7Y 15.62% Slotnik Capital, LLC 12.01% Twin Securities, Inc. 3Y 7Y 10.07% Sand Grove Capital Management LLP 3Y 7Y 8.11% HARVEST MANAGEMENT LLC 3Y 7Y 7.61% Slotnik Capital, LLC 6.72% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 6.39% TIG Advisors, LLC 3Y 7Y 6.02% KRYGER CAPITAL Ltd 3Y 5.82% PSquared Asset Management AG 3Y 7Y 5.68%
← Back to Boxer Capital, LLC Holdings